Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Angiocentric Glioma
23%
Azacitidine
23%
B7-H3
23%
Belgium
23%
Cavitron Ultrasonic Surgical Aspirator
23%
Central Nervous System Tumors
55%
Children with Cancer
23%
Childrens
23%
Clinical Trials
23%
Cure Fraction
23%
Data Quality
23%
Data Reporting
23%
Diffuse Astrocytoma
23%
EUROCARE
23%
European Countries
23%
Gemtuzumab Ozogamicin
23%
Glioma Subtypes
23%
Group Studies
23%
High-grade Glioma
20%
Imaging Biomarkers
23%
Immune Tumor Microenvironment
23%
Immunohistochemistry
23%
Infant Patients
23%
Juvenile Myelomonocytic Leukemia
23%
Long-term Survival
23%
Myelodysplastic Syndrome
23%
Netherlands
46%
Observed Survival
31%
Pediatric Brain Tumor
50%
Pediatric Glioma
46%
Pediatric Patients
28%
Phase I Study
23%
Population-based Cancer Registry
27%
Population-based Cohort Study
23%
Population-based Study
79%
Preadolescent children
46%
Registration Practices
20%
Registry Research
23%
Relapsed or Refractory Acute Lymphoblastic Leukemia
23%
Sex-related
23%
Survival Disparities
23%
Survival Outcomes
25%
Survival Percentage
23%
Survival Rate
32%
T2-FLAIR Mismatch
23%
Tissue Fragment
23%
Tumor
45%
Vidaza
23%
Young Adolescents
46%
Young children
23%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
23%
Adolescence
46%
Age Groups
16%
Azacitidine
23%
Biological Marker
26%
Biopsy Technique
8%
Cancer
24%
Cancer Incidence
9%
Cancer Mortality
9%
Cancer Registry
31%
Central Nervous System Tumor
79%
Childhood Cancer
11%
Clinical Study
11%
Clinical Trial
25%
Cohort Analysis
23%
Diseases
6%
Ependymoma
11%
Fluid Attenuated Inversion Recovery
23%
Ganglioglioma
100%
Ganglioneuroblastoma
13%
Hematopoietic Stem Cell Transplantation
9%
Immunohistochemistry
23%
Inotuzumab Ozogamicin
23%
Intracranial Tumor
5%
Juvenile Myelomonocytic Leukemia
23%
Long Term Survival
23%
Malignant Neoplasm
7%
Medulloblastoma
5%
Messenger RNA
6%
Minimal Residual Disease
9%
Myelodysplastic Syndrome
23%
Neoplasm
40%
Oligoastrocytoma
23%
Overall Survival
9%
Pediatric Brain Tumor
23%
Pediatric Cancer
23%
Pediatrics
95%
Pediatrics Patient
27%
Pilocytic Astrocytoma
15%
Protein Expression
9%
Sex Differences
11%
Survival Rate
31%
Tumor
50%
Tumor Cell
6%
Tumor Immune Microenvironment
23%
Ultrasound
23%
